We are live on ! Find out more
BC

Burney Company Portfolio holdings

AUM $3.71B
1-Year Est. Return 37.66%
This Fund
S&P 500
This Quarter Est. Return
-2.12%
1 Year Est. Return
+37.66%
3 Year Est. Return
+121.71%
5 Year Est. Return
+168%
10 Year Est. Return
+562.51%
AUM
$2.13B
AUM Growth
-$47.3M
Cap. Flow
+$24.9M
Cap. Flow %
1.17%
Top 10 Hldgs %
22.82%
Holding
600
New
29
Increased
182
Reduced
295
Closed
38

Top Sells

Rank Stock Value
1
EIX icon
Edison International
EIX
+$9.48M
2
ADI icon
Analog Devices
ADI
+$8.68M
3
TRV icon
Travelers Companies
TRV
+$5.11M
4
WEN icon
Wendy's
WEN
+$4.93M
5
COF icon
Capital One
COF
+$4.27M

Sector Composition

Rank Sector Weight
1 Technology 20.87%
2 Consumer Discretionary 13.43%
3 Healthcare 13.06%
4 Industrials 12.14%
5 Financials 9.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NXPI icon
201
NXP Semiconductors
NXPI
$61.8B
$2.32M 0.11%
11,626
+2,029
+21% +$420K
CI icon
202
Cigna
CI
$76.1B
$2.32M 0.11%
8,102
-140
-2% -$39.9K
RIO icon
203
Rio Tinto
RIO
$158B
$2.3M 0.11%
36,149
+431
+1% +$27.5K
PFE icon
204
Pfizer
PFE
$142B
$2.3M 0.11%
69,284
+1,816
+3% +$64.2K
G icon
205
Genpact
G
$5.99B
$2.29M 0.11%
+63,369
New +$2.35M
MS icon
206
Morgan Stanley
MS
$330B
$2.29M 0.11%
28,078
-6,395
-19% -$555K
CMCSA icon
207
Comcast
CMCSA
$84B
$2.28M 0.11%
51,351
-824
-2% -$36.8K
DOX icon
208
Amdocs
DOX
$5.87B
$2.27M 0.11%
26,855
+741
+3% +$66.9K
GS icon
209
Goldman Sachs
GS
$302B
$2.26M 0.11%
6,998
-415
-6% -$139K
AMP icon
210
Ameriprise Financial
AMP
$48.1B
$2.26M 0.11%
6,854
+97
+1% +$33.1K
UTHR icon
211
United Therapeutics
UTHR
$26.2B
$2.25M 0.11%
9,964
+300
+3% +$69.1K
FDX icon
212
FedEx
FDX
$73B
$2.2M 0.1%
8,305
-33
-0.4% -$8.58K
BPOP icon
213
Popular Inc
BPOP
$11.2B
$2.19M 0.1%
34,798
-6,762
-16% -$447K
GLPI icon
214
Gaming and Leisure Properties
GLPI
$12.7B
$2.18M 0.1%
47,866
+619
+1% +$29.5K
MMM icon
215
3M
MMM
$90.8B
$2.17M 0.1%
27,751
-155
-0.6% -$13.3K
ADI icon
216
Analog Devices
ADI
$179B
$2.14M 0.1%
12,204
-47,095
-79% -$8.68M
VZ icon
217
Verizon
VZ
$193B
$2.08M 0.1%
64,213
-175
-0.3% -$5.91K
NUE icon
218
Nucor
NUE
$58.5B
$2.07M 0.1%
13,271
-491
-4% -$81.3K
PBH icon
219
Prestige Consumer Healthcare
PBH
$2.37B
$2.05M 0.1%
35,780
-4,973
-12% -$301K
SHEL icon
220
Shell
SHEL
$250B
$2.04M 0.1%
31,668
-1,054
-3% -$65.6K
SPYG icon
221
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
$51B
$2.01M 0.09%
33,875
+2,826
+9% +$173K
CRUS icon
222
Cirrus Logic
CRUS
$6.65B
$1.99M 0.09%
+26,853
New +$2.1M
SUPN icon
223
Supernus Pharmaceuticals
SUPN
$2.65B
$1.98M 0.09%
71,711
-114,648
-62% -$3.49M
ASB icon
224
Associated Banc-Corp
ASB
$5.8B
$1.96M 0.09%
114,440
-624
-0.5% -$11K
BALL icon
225
Ball Corp
BALL
$17.4B
$1.96M 0.09%
39,296
-82
-0.2% -$4.47K

Similar funds

Burney Company's Q3 2023 Portfolio in Review

As of Q3 2023, Burney Company held 600 positions worth $2.13B, down 2.2% from $2.18B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Burney Company's Q3 2023 filing shows 29 new, 182 increased, 295 reduced and 38 closed positions. Its largest new stake was Goldman Sachs Access Treasury 0-1 Year ETF: 250,111 shares worth $25M. The largest sale was Edison International, an estimated $9.48M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Burney Company's largest Q3 2023 buy was Goldman Sachs Access Treasury 0-1 Year ETF: 250,111 shares worth $25M.
  • Burney Company added most to Alphabet (Google) Class A in Q3 2023, an estimated $8.53M increase.
  • Burney Company's biggest Q3 2023 reduction was Edison International, cutting an estimated $9.48M.
  • Burney Company fully exited Ligand Pharmaceuticals in Q3 2023, selling an estimated $3.75M.
  • Burney Company's ten largest holdings make up 23% of its $2.13B portfolio in Q3 2023.
  • Burney Company opened 29 new positions and closed 38 in Q3 2023.
  • Burney Company's portfolio value fell 2.2% quarter-over-quarter to $2.13B.

Based on Burney Company's 13F filing for Q3 2023, filed 8 Nov 2023.